JP Morgan sets Neurogene price target at $60
JP Morgan announced a $60.00-per-share price target for Neurogene, according to the ratings update cited by Benzinga.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.